Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40


Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives.

Mukherjee A, Waters AK, Kalyan P, Achrol AS, Kesari S, Yenugonda VM.

Int J Nanomedicine. 2019 Mar 19;14:1937-1952. doi: 10.2147/IJN.S198353. eCollection 2019. Review.


Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors.

Piccioni DE, Achrol AS, Kiedrowski LA, Banks KC, Boucher N, Barkhoudarian G, Kelly DF, Juarez T, Lanman RB, Raymond VM, Nguyen M, Truong JD, Heng A, Gill J, Saria M, Pingle SC, Kesari S.

CNS Oncol. 2019 Jun;8(2):CNS34. doi: 10.2217/cns-2018-0015. Epub 2019 Mar 11.


Brain metastases.

Achrol AS, Rennert RC, Anders C, Soffietti R, Ahluwalia MS, Nayak L, Peters S, Arvold ND, Harsh GR, Steeg PS, Chang SD.

Nat Rev Dis Primers. 2019 Jan 17;5(1):5. doi: 10.1038/s41572-018-0055-y. Review.


Diabetes Insipidus following Endoscopic Transsphenoidal Surgery for Pituitary Adenoma.

Ajlan AM, Abdulqader SB, Achrol AS, Aljamaan Y, Feroze AH, Katznelson L, Harsh GR.

J Neurol Surg B Skull Base. 2018 Apr;79(2):117-122. doi: 10.1055/s-0037-1604363. Epub 2017 Aug 3.


Cavernous Sinus Involvement by Pituitary Adenomas: Clinical Implications and Outcomes of Endoscopic Endonasal Resection.

Ajlan A, Achrol AS, Albakr A, Feroze AH, Westbroek EM, Hwang P, Harsh GR 4th.

J Neurol Surg B Skull Base. 2017 Jun;78(3):273-282. doi: 10.1055/s-0036-1598022. Epub 2017 Jan 23.


Revealing cancer subtypes with higher-order correlations applied to imaging and omics data.

Graim K, Liu TT, Achrol AS, Paull EO, Newton Y, Chang SD, Harsh GR 4th, Cordero SP, Rubin DL, Stuart JM.

BMC Med Genomics. 2017 Mar 31;10(1):20. doi: 10.1186/s12920-017-0256-3.


Magnetic resonance perfusion image features uncover an angiogenic subgroup of glioblastoma patients with poor survival and better response to antiangiogenic treatment.

Liu TT, Achrol AS, Mitchell LA, Rodriguez SA, Feroze A, Iv M, Kim C, Chaudhary N, Gevaert O, Stuart JM, Harsh GR, Chang SD, Rubin DL.

Neuro Oncol. 2017 Jul 1;19(7):997-1007. doi: 10.1093/neuonc/now270.


Personalized Medicine in Cerebrovascular Neurosurgery: Precision Neurosurgical Management of Cerebral Aneurysms and Subarachnoid Hemorrhage.

Achrol AS, Steinberg GK.

Front Surg. 2016 Jun 22;3:34. doi: 10.3389/fsurg.2016.00034. eCollection 2016. Review.


Pituitary Apoplexy Associated with Carotid Compression and a Large Ischemic Penumbra.

Sussman ES, Ho AL, Pendharkar AV, Achrol AS, Harsh GR 4th.

World Neurosurg. 2016 Aug;92:581.e7-581.e13. doi: 10.1016/j.wneu.2016.06.040. Epub 2016 Jun 16.


Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.

Zhang M, Hutter G, Kahn SA, Azad TD, Gholamin S, Xu CY, Liu J, Achrol AS, Richard C, Sommerkamp P, Schoen MK, McCracken MN, Majeti R, Weissman I, Mitra SS, Cheshier SH.

PLoS One. 2016 Apr 19;11(4):e0153550. doi: 10.1371/journal.pone.0153550. eCollection 2016.


High-Resolution Microfluidic Single-Cell Transcriptional Profiling Reveals Clinically Relevant Subtypes among Human Stem Cell Populations Commonly Utilized in Cell-Based Therapies.

Rennert RC, Schäfer R, Bliss T, Januszyk M, Sorkin M, Achrol AS, Rodrigues M, Maan ZN, Kluba T, Steinberg GK, Gurtner GC.

Front Neurol. 2016 Mar 22;7:41. doi: 10.3389/fneur.2016.00041. eCollection 2016. Review.


Multiple Subsets of Brain Tumor Initiating Cells Coexist in Glioblastoma.

Rennert RC, Achrol AS, Januszyk M, Kahn SA, Liu TT, Liu Y, Sahoo D, Rodrigues M, Maan ZN, Wong VW, Cheshier SH, Chang SD, Steinberg GK, Harsh GR, Gurtner GC.

Stem Cells. 2016 Jun;34(6):1702-7. doi: 10.1002/stem.2359. Epub 2016 Mar 28.


Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.

Liu TT, Achrol AS, Mitchell LA, Du WA, Loya JJ, Rodriguez SA, Feroze A, Westbroek EM, Yeom KW, Stuart JM, Chang SD, Harsh GR 4th, Rubin DL.

AJNR Am J Neuroradiol. 2016 Apr;37(4):621-8. doi: 10.3174/ajnr.A4631. Epub 2016 Jan 7.


Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities.

Itakura H, Achrol AS, Mitchell LA, Loya JJ, Liu T, Westbroek EM, Feroze AH, Rodriguez S, Echegaray S, Azad TD, Yeom KW, Napel S, Rubin DL, Chang SD, Harsh GR 4th, Gevaert O.

Sci Transl Med. 2015 Sep 2;7(303):303ra138. doi: 10.1126/scitranslmed.aaa7582.


Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features.

Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, Cheshier SH, Napel S, Zaharchuk G, Plevritis SK.

Radiology. 2015 Jul;276(1):313. doi: 10.1148/radiol.2015154019. No abstract available.


MRI surrogates for molecular subgroups of medulloblastoma.

Perreault S, Ramaswamy V, Achrol AS, Chao K, Liu TT, Shih D, Remke M, Schubert S, Bouffet E, Fisher PG, Partap S, Vogel H, Taylor MD, Cho YJ, Yeom KW.

AJNR Am J Neuroradiol. 2014 Jul;35(7):1263-9. doi: 10.3174/ajnr.A3990. Epub 2014 May 15.


Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.

Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, Cheshier SH, Napel S, Zaharchuk G, Plevritis SK.

Radiology. 2014 Oct;273(1):168-74. doi: 10.1148/radiol.14131731. Epub 2014 May 12. Erratum in: Radiology. 2015 Jul;276(1):313.


Multiplex meta-analysis of medulloblastoma expression studies with external controls.

Morgan AA, Achrol AS, Li MD, Khatri PJ, Cheshier SH.

Pac Symp Biocomput. 2014:99-109.


In reply. The genetics of moyamoya disease: recent insights into the pathogenesis of the disease.

Achrol AS, Khan N, Steinberg GK.

Neurosurgery. 2013 Feb;72(2):E321-2. doi: 10.1227/NEU.0b013e31827bc1c1. No abstract available.


Sex differences in clinical presentation and treatment outcomes in Moyamoya disease.

Khan N, Achrol AS, Guzman R, Burns TC, Dodd R, Bell-Stephens T, Steinberg GK.

Neurosurgery. 2012 Sep;71(3):587-93; discussion 593. doi: 10.1227/NEU.0b013e3182600b3c.


Gene expression profiling of blood in brain arteriovenous malformation patients.

Weinsheimer SM, Xu H, Achrol AS, Stamova B, McCulloch CE, Pawlikowska L, Tian Y, Ko NU, Lawton MT, Steinberg GK, Chang SD, Jickling G, Ander BP, Kim H, Sharp FR, Young WL.

Transl Stroke Res. 2011 Dec 1;2(4):575-87. doi: 10.1007/s12975-011-0103-3.


Clinical neuroproteomics and biomarkers: from basic research to clinical decision making.

Shoemaker LD, Achrol AS, Sethu P, Steinberg GK, Chang SD.

Neurosurgery. 2012 Mar;70(3):518-25. doi: 10.1227/NEU.0b013e3182333a26.


Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population.

Gabriel RA, Kim H, Sidney S, McCulloch CE, Singh V, Johnston SC, Ko NU, Achrol AS, Zaroff JG, Young WL.

Stroke. 2010 Jan;41(1):21-6. doi: 10.1161/STROKEAHA.109.566018. Epub 2009 Nov 19.


Pathogenesis and radiobiology of brain arteriovenous malformations: implications for risk stratification in natural history and posttreatment course.

Achrol AS, Guzman R, Varga M, Adler JR, Steinberg GK, Chang SD.

Neurosurg Focus. 2009 May;26(5):E9. doi: 10.3171/2009.2.FOCUS0926. Review.


Pathophysiology and genetic factors in moyamoya disease.

Achrol AS, Guzman R, Lee M, Steinberg GK.

Neurosurg Focus. 2009 Apr;26(4):E4. doi: 10.3171/2009.1.FOCUS08302. Review.


Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation.

Kim H, Hysi PG, Pawlikowska L, Poon A, Burchard EG, Zaroff JG, Sidney S, Ko NU, Achrol AS, Lawton MT, McCulloch CE, Kwok PY, Young WL.

Cerebrovasc Dis. 2009;27(2):176-82. doi: 10.1159/000185609. Epub 2008 Dec 18.


Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment.

Achrol AS, Kim H, Pawlikowska L, Trudy Poon KY, McCulloch CE, Ko NU, Johnston SC, McDermott MW, Zaroff JG, Lawton MT, Kwok PY, Young WL.

Neurosurgery. 2007 Oct;61(4):731-9; discussion 740.


Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients.

Kim H, Sidney S, McCulloch CE, Poon KY, Singh V, Johnston SC, Ko NU, Achrol AS, Lawton MT, Higashida RT, Young WL; UCSF BAVM Study Project.

Stroke. 2007 Sep;38(9):2430-7. Epub 2007 Aug 2.


Estimation of fusiform intracranial aneurysm growth by serial magnetic resonance imaging.

Dispensa BP, Saloner DA, Acevedo-Bolton G, Achrol AS, Jou LD, McCulloch CE, Johnston SC, Higashida RT, Dowd CF, Halbach VV, Ko NU, Lawton MT, Martin AJ, Quinnine N, Young WL.

J Magn Reson Imaging. 2007 Jul;26(1):177-83.


MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations.

Chen Y, Fan Y, Poon KY, Achrol AS, Lawton MT, Zhu Y, McCulloch CE, Hashimoto T, Lee C, Barbaro NM, Bollen AW, Yang GY, Young WL.

Front Biosci. 2006 Sep 1;11:3121-8.


Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations.

Pawlikowska L, Poon KY, Achrol AS, McCulloch CE, Ha C, Lum K, Zaroff JG, Ko NU, Johnston SC, Sidney S, Marchuk DA, Lawton MT, Kwok PY, Young WL.

Neurosurgery. 2006 May;58(5):838-43; discussion 838-43.


Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations.

Achrol AS, Pawlikowska L, McCulloch CE, Poon KY, Ha C, Zaroff JG, Johnston SC, Lee C, Lawton MT, Sidney S, Marchuk DA, Kwok PY, Young WL; UCSF BAVM Study Project.

Stroke. 2006 Jan;37(1):231-4. Epub 2005 Dec 1.


Interleukin-6 involvement in brain arteriovenous malformations.

Chen Y, Pawlikowska L, Yao JS, Shen F, Zhai W, Achrol AS, Lawton MT, Kwok PY, Yang GY, Young WL.

Ann Neurol. 2006 Jan;59(1):72-80.


Polymorphisms in transforming growth factor-beta-related genes ALK1 and ENG are associated with sporadic brain arteriovenous malformations.

Pawlikowska L, Tran MN, Achrol AS, Ha C, Burchard E, Choudhry S, Zaroff J, Lawton MT, Castro R, McCulloch CE, Marchuk D, Kwok PY, Young WL; UCSF BAVM Study Project.

Stroke. 2005 Oct;36(10):2278-80. Epub 2005 Sep 22.


Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations.

Fullerton HJ, Achrol AS, Johnston SC, McCulloch CE, Higashida RT, Lawton MT, Sidney S, Young WL; UCSF BAVM Study Project.

Stroke. 2005 Oct;36(10):2099-104. Epub 2005 Sep 1.


Cerebral blood flow changes after endovascular treatment of cerebrovascular stenoses.

Ko NU, Achrol AS, Chopra M, Saha M, Gupta D, Smith WS, Higashida RT, Young WL.

AJNR Am J Neuroradiol. 2005 Mar;26(3):538-42.


Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations.

Lawton MT, Du R, Tran MN, Achrol AS, McCulloch CE, Johnston SC, Quinnine NJ, Young WL.

Neurosurgery. 2005 Mar;56(3):485-93; discussion 485-93.


Magnetic resonance perfusion tracks 133Xe cerebral blood flow changes after carotid stenting.

Ko NU, Achrol AS, Martin AJ, Chopra M, Saloner DA, Higashida RT, Young WL.

Stroke. 2005 Mar;36(3):676-8. Epub 2005 Feb 3.


Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations.

Pawlikowska L, Tran MN, Achrol AS, McCulloch CE, Ha C, Lind DL, Hashimoto T, Zaroff J, Lawton MT, Marchuk DA, Kwok PY, Young WL; UCSF BAVM Study Project.

Stroke. 2004 Oct;35(10):2294-300. Epub 2004 Aug 26.


Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population.

Halim AX, Johnston SC, Singh V, McCulloch CE, Bennett JP, Achrol AS, Sidney S, Young WL.

Stroke. 2004 Jul;35(7):1697-702. Epub 2004 May 27.


Supplemental Content

Loading ...
Support Center